80O Patient (pt) preference and satisfaction with the subcutaneous fixed-dose combination of pertuzumab (P) and trastuzumab (H) in pts with HER2-positive early breast cancer (HER2+ eBC): Interim analysis of the open-label, randomised cross-over PHranceSCa study
Titel:
80O Patient (pt) preference and satisfaction with the subcutaneous fixed-dose combination of pertuzumab (P) and trastuzumab (H) in pts with HER2-positive early breast cancer (HER2+ eBC): Interim analysis of the open-label, randomised cross-over PHranceSCa study
Auteur:
O'Shaughnessy, J. Sousa, S.P. Cruz, J. Fallowfield, L.J. Auvinen, P. Pulido, C. Cvetanovic, A. Wilks, S. Ribeiro, L. Burotto, M. Klingbiel, D. Messeri, D. Alexandrou, A. Trask, P. Fredriksson, J. Stamatovic, L.